The cytoplasmic tail of CD44 is required for basolateral localization in epithelial MDCK cells but does not mediate association with the detergent-insoluble cytoskeleton of fibroblasts by unknown
The Cytoplasmic Tail of CD44 Is Required for Basolateral 
Localization in Epithelial MDCK Cells but Does Not Mediate Association 
with the Detergent-insoluble Cytoskeleton of Fibroblasts 
Stephen J. Neame and Clare M. Isacke 
Department of Biology, Imperial College of Science, Technology and Medicine, Prince Consort Road, London SW7 2BB, 
United Kingdom 
Abstract.  A  number of recent reports on the traffick- 
ing of receptor proteins in MDCK epithelial cells have 
provided evidence that delivery to the basolateral do- 
main requires a  specific targeting  sequence and that 
deletion of this  sequence results in constitutive expres- 
sion on the apical surface.  To date, these studies have 
concentrated on receptors which are competent for in- 
ternalization  via the clathrin  coated pits.  We have ex- 
amined the localization of a resident plasma membrane 
protein by transfecting human CD44 into MDCK cells. 
Using human specific and cross-species reactive anti- 
bodies, we show that in MDCK cells both the endoge- 
nous and transfected wild-type CIM4 are found on the 
basolateral surface where they are restricted to the lat- 
eral domain.  Deletion of the CD44 cytoplasmic tail 
reduces the half life of this mutant protein and causes 
it to be expressed both on the apical surface and to a 
significant extent within the cell. We have also used 
biochemical and morphologial analysis to investigate 
the interaction of CD44 with the cytoskeleton in de- 
tergent extracted cells. Strikingly different extraction 
results were obtained between epithelial and fibroblast 
cells. However, there is no difference in the Triton 
X-100 solubility of the transfected wild-type and tail- 
less CD44 in fibroblasts and both forms of the protein 
remain associated with the cortical cytoskeleton after 
Triton X-100 extraction.  These results demonstrate 
that the sequence present in the cytoplasmic domain of 
CD44 responsible for its distribution in epithelial cells 
is functionally and spatially separate from the ability 
of this protein to associate with the cytoskeleton. 
C 
D44  is  an  abundant  transmembrane  glycoprotein 
which has been implicated to play a role in a number 
of important physiological  processes including  the 
homing  of lymphocytes and prothymocytes, T cell activa- 
tion, cell adhesion, cell migration  and metastatic spread (re- 
viewed in Haynes et al., 1989, 1991). The question arises as 
to how one molecule might  fulfil these somewhat diverse 
functions. 
One observed mechanism  is  the expression  of multiple 
forms of the CD44 protein.  The  most abundant  form of 
CD44 (CD44H) is an 80-100 kD glycoprotein present on 
fibroblasts and haematopoietic cells which functions as a re- 
ceptor for the extracellular  matrix  glycosaminoglycan,  hy- 
aluronate (Aruffo et al., 1990; Culty et al., 1990; Lesley et 
al., 1990). Higher molecular weight CD44 forms have been 
detected on a variety of other cell types (Omary et al., 1988). 
cDNA cloning  has demonstrated that these result from the 
insertion  of a variable  stretch  of amino acids into the ex- 
tracellular domain of CD44 (Brown et al., 1991; Dougherty 
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et al., 1991; Gunthert et al., 1991; Stamenkovic et al., 1991; 
Jackson et al., 1992) and in some cases these higher molecu- 
lar weight forms have been demonstrated to have an altered 
behavior as compared to their CD44H counterpart (Gun- 
thert et al., 1991; Stamenkovic et al., 1991; Sy et al., 1991; 
Arch et al.,  1992). 
A second potential mechanism for the regulation of CD44 
function is via the interaction  of its cytoplasmic tail with in- 
tracellular components as there is increasing  evidence that 
the binding function of other adhesion molecules is regulated 
in this manner (Nagafuchi  and Takeichi,  1988; Jaffe et al., 
1990).  Detergent  extraction  experiments  (Tarone  et  al., 
1984; Lacy and Underhill,  1987; Carter and Wayner, 1988; 
Camp et al., 1991), membrane mobility studies (Jacobson et 
al., 1984) and in vitro analysis (Kalomiris and Bourguignon, 
1988; Lokeshwar and Bourguignon,  1991) have all suggested 
that  CD44 is associated with the underlying  cytoskeleton 
whereas the experiments of Lesley et al. (1992) have demon- 
strated  a role for the CD44 cytoplasmic tail in the control 
of hyaluronate  binding.  The cytoplasmic tail of CD44 is 
highly conserved between species and subject to phosphory- 
lation on serine residues (Carter and Wayner, 1988; Neame 
and Isacke,  1992). 
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pressed on a variety of different epithelia in vivo but that it 
is particularly abundant on cells which are rapidly proliferat- 
ing. They argue that this pattern of CD44 expression may be 
important in epithelial maturation and in this respect it is in- 
teresting that CD44 is found expressed at high levels in epi- 
thelial tumours (Stamenkovic et al., 1989;  1991). An under- 
standing of the mechanisms regulating CD44 function may 
prove important in understanding normal epithelial biogene- 
sis and the aberrant events associated with tumor growth. 
For this purpose we have taken the approach of studying the 
wild-type CD44H and a tailless CD44H mutant expressed 
in MDCK cells. MDCK cells provide an in vitro model of 
simple epithelia whereby an upper  apical  surface,  which 
faces outwards in the body (e.g., towards the lumen of the 
kidney tubules), is delineated from the basolateral surface by 
the presence of tight junctions. The basolateral surface can 
be  further  divided  into  the  lateral  region  (involved  in 
cell-cell interactions) and the basal region (in contact with 
the underlying basal lamina). The formation of these func- 
tionally distinct domains is associated with the functional 
segregation  of membrane  proteins  (reviewed  in  Nelson, 
1989;  Hopkins, 1991; Mostov et al.,  1992).  In the experi- 
ments described here, we demonstrate that the CD44 cyto- 
plasmic tail plays an important role in CD44 distribution in 
epithelial cells but this function appears to be distinct from 
the ability of the CD44 protein to interact with the fibroblast 
cortical cytoskeleton. 
Materials and Methods 
Isolation of  a Human CD44H cDNA Clone 
and Generation of CD44H Tailless Mutants 
A  eDNA  clone  encoding  the  human  haematopoietic  form  of  CD44 
(CIM4H) was isolated by PCR using oligonucleotides based upon the pub- 
lished sequence of Stamenkovic et ai. (1989).  The reaction conditions were 
as follows: 1 #g each of oligonncleotides C3 (5'GGATCCTCCAGCTCC- 
TTTCG; bases 58 to 77) and C4 (5'GTCCCAGCTCCCTGTAATGG; bases 
1247 to 1266),  1 #g hZAP human fibroblast eDNA library, l  mM dNTPs 
(Pharmacia LKB Biotechnology, Inc., Piscataway,  NJ), 2.5 U Taq polymer- 
ase (Perkin Elmer Cetus, Norwalk, CT) in 2.5 mM MgSO4,  10 mM Tris 
pH 8.3, 50 mM KC1, 0.01% gelatin (final vol 50 #1). PCR was performed 
using a Tempeycler (Coy Lab Products, Inc., Ann Arbor, MI) with 30 cycles 
of 1 rain at 940C,  2 rain at 60"C and 2 rain at 72"C followed by 30 min 
at 37"C with additional dNTPs and Klenow fragment of DNA polymerase 
I to fill in any single stranded ends. The reaction products were separated 
on a  I% agarose gel and a band with the expected size of 1199 bp was ex- 
cised, purified and ligated into the Sma 1 site of  pUC19. Restriction enzyme 
digests and partial sequencing were performed to check the orientation and 
identity of the CD44H insert. 
To generate a CIM4H tailless mutant, oligonucleotide C5 (5'CAGTCA- 
ACAGTCGAAGAAGGTGAGGC~; corresponding to bases 978 to 1004) 
as synthesized. A is a change from a T in the wild-type (WT) 1 CD44H se- 
quence, changing a cys codon to a TGA stop codon. Under the same PCR 
conditions as described above using oligonucleotides C5 and C4 with a tem- 
plate ofWT CD44H in pUCI9, a 287-bp fragment was produced which en- 
coded part of the putative transmembrane and COOH-terminai domain of 
CD44H including the desired mutation. This fragment was then digested 
with BstX 1 and Hinc II and the resulting 235-bp mutant fragment was iso- 
lal~t from a 1% agarose gel. WT CD44H in pUCI9 was cleaved with BstX 
I and the 3474-bp and 411-bp fragments were purified, the 411-bp fragment 
was further digested with Hinc II giving a  176-bp  fragment which was 
purified and a 235-bp fragment which was discarded. The 3474-bp and 176- 
1. Abbreviations  used in this paper:  ECL, enhanced chemiluminescence; 
LDL, low density lipoprotein; WT,  wild-type. 
bp WT CIM4H/pUC19 fragments and the mutated 235-bp fragment were 
then ligated. The WT CD44H and tailless (T-) CD44H were excised from 
the pUC19 vector with EcoR 1 and Xba 1. A eukaryotic expression vector 
pSRc~-neo (Takebe et ai., 1988; DNAX, Palo Alto, California) was linear- 
ized with BamH 1. This vector and the excised CD44 clones were treated 
with the Klenow fragment of DNA polymerase I and dNTPs, ligated to- 
gather and the orientation of the insert was checked by restriction en- 
donuclease  digestion.  To  generate  a  CD44H  tailless  variant,  the  WT 
CD44H eDNA in pUC19 was digested with Pst I and the 826- and ll8-bp 
fragments  were  purified.  The  ll8-bp  fragment  was  treated  with  S  I 
nuclease, end filled and digested with BstX I. The 826-bp fragment was 
digested with Taq I, the 641-bp fragment was purified, end filled, digested 
with BstX I and the 182-bp fragment was purified. CD44H eDNA in pSRt~- 
neo was digested with BstX 1, the large fragment consisting of the vector 
and much of the CIM4H eDNA was purified and ligated with eqnimolar 
concentrations of the 118 bp BstX 1 digest and 182-bp fragment. Several 
of the ligation products were sequenced, one of these sequences encoded 
a tailless CD44H mutant in which the carboxy-terminai arg-arg-arg of the 
original T- CIM4H had been substituted by arg-trp-thr. This second tailless 
mutant was designated PT16  CD44H. 
Cell Lines and Antibodies 
All cell lines were maintained in DME supplemented  with 10 % FCS. F1084 
human embryonic diploid fibroblasts and MDCK epithelial cells were ob- 
tained from C. R. Hopkins (University College, London). Swiss 3T3 fibro- 
blasts were obtained from E. Rozengurt, (ICRF, London). Cell lines were 
transfected by electroporation using a modification of the method of Chu 
et al. (1987).  0.5-1.0  x  107 MDCK or 2-4  x  106 Swiss or NIH 3"1"3 cells 
were trypsinized, washed in DME plus 10% FCS, washed twice in HeBS 
(20 ram Hepes pH 7.05,  137 mM NaC1,  5 mM KCI, 0.7 mM Na2HPO4, 
6 mM o-glucose) and resuspended in 250 #1 of HeBS containing 20 #g of 
the pSRa-neo construct. Electroporation was at 250 #Farads, 270 V and 
infinite ohms in 0.4 cm cuvettes in a Gene Pulser (BioRed Laboratories, 
Richmond, CA). The cells were allowed to recover for 10 rain and then 
plated into 10-cm tissue culture dishes in DME plus 10% FCS for 24-48 h. 
The cells were then trypsinized and replated into 96 well tissue culture 
plates at a range of densities (90, 9, and 1% of an electroporation per 96 
well plate) in DME plus 10% FCS supplemented with 0.5 mg/ml (MDCK 
cells), 0.4 mg/ml (Swiss 3T3 cells), or 0.2 mg/ml (NIH 3T3 cells) of G418 
(GIBCO-BRL, Gaithersburg, MD). G418 resistant clones were screened by 
immunoflnorescence  for expression of  transfected human CD44H and posi- 
tive clones were then maintained in 0.3 mg/ml (MDCK), 0.2 mg/ml (Swiss 
3T3),  or 0.1 mg/ml (NIH 31"3) of G418. For each of the transfected MDCK 
cell lines, at least five individual clones were characterized and for the trans- 
fected fibroblast cell lines, at least two individual clones were characterized. 
Where indicated, cultures of Swiss 3T3 cells in which 60-80% of the cells 
were expressing either WT, T- or PTI6 forms of CIM4H were produced by 
electroporating 5  ×  106 cells with 50 ~,g of the pSRa-neo construct at 
300 V and 250 #Farads, culturing for 2-3 d in DME plus 10% FCS followed 
by 15-20 d in DME plus 10%  FCS and 0.3 mg/ml G418. 
El/2.1 is a mouse mAb which is specific for human CD44 (Isacke et al., 
1986).  IM7.8.1 is a rat anti-CD44 mAb (Trowbridge et al.,  1982).  H68.4 
is a  mouse anti-transferrin receptor mAb (White et al.,  1992)  and anti- 
annexin II is a  rabbit polyclonal antiserum (Cooper and Hunter,  1983). 
FITC and HRP-conjugated anti-mouse, anti-rat and anti-rabbit Ig and HRP- 
conjugated  streptavidin were obtained  from Jackson  ImmunoResearch. 
Other antibodies were 1251-labeled by the chloramine T  method (Hunter 
and Greenwood, 1962). 
Immunofluorescence 
For general studies cells were cultured on glass coverslips, fixed in 3 % 
paraformaldehyde (Agar Scientific, Stansted, Essex, UK) for 10 rain and 
blocked with 10 mM glycine pH 8.0. To look at polarized expression in 
MDCK cell clones, 1-2 ×  10  ~ cells were cultured on 24 nun transwell 0.4- 
#m filters (Costar Corp., Cambridge, MA) for 2-3 d and tested for tight 
junction formation as previously described (Neame and Isacke, 1992).  Im- 
munofluorescence was performed exactly as described by Isacke et al., 
(1990) with 0.2 % saponin present throughout the experiment to permeabi- 
lize the cells. An ascites preparation of El/2 was used at a dilution of 1:100, 
hybridoma supernatant preparations of IM7 were used at a dilution of 1:2 
and FITC-conjugated anti-mouse or anti-rat Ig were used at 10 #g/rni. Cov- 
erslips were mounted cells down on glass slides and filter sections were 
placed cells upward in mounting medium on glass slides and then sealed 
under a  coverslip. Microscopy was performed using a  Leitz Aristoplan 
The Journal  of Cell Biology,  Volume 121, 1993  1300 fluorescence microscope, Nikon Microphot SX or a Nikon Optiphot micro- 
scope in conjunction with a confocal laser scanning unit (model MRC600, 
BioRad Laboratories). 
Biotinylation of  Plasma Membrane Proteins 
1-2 x  l06 MDCK cells were cultured for 3-4 d on transwell filters and the 
integrity of the tight junctions was checked. Duplicate filters were washed 
twice in PBS,  incubated in PBS with 0.5  mg/ml NHS-SS-Biotin  (Pierce 
Chemical Co., Rockford,  IL) on either the apical or basal side for 30 rain 
at 4°C, washed twice in 0.2 M glycine in PBS and lysed in 0.4 rul NDET 
(1% Nonidet P40, 0.4% sodium deoxycholate,  66 mM EDTA,  10 mM Tris 
pH 7.4). Lysates were incubated on ice for 15 rain, clarified by centrifnga- 
tion at 12,000 g for 10 rain, the supernatants were removed to a fresh tube 
and SDS added to a concentration  of 0.3 %. All subsequent procedures were 
carried out on ice.  Lysates  were precleared by incubation with 100/~! of 
fixed Staphylococcus  aureus bacteria (Pansorbin, Calbiochem Corp.,  La 
Jolla, CA) for 30 min on ice, human CD44H was inununoprecipitated by 
incubating the lysates with mAb EF2 for 60 rain and then with anti-mouse 
Ig bound to 50/zl protein-A agarose (BioRad Laboratories) for 60 min. The 
immunoprecipitates were washed four times in NDET plus 0.3%  SDS, 
resuspended in nonreducing sample buffer, boiled for 2 rain, resolved  by 
electrophoresis on a  10% SDS polyacrylamide gel and then transferred to 
nitrocellulose membranes (Hybond C extra, Amersham Corp., Arlington 
Heights, IL). The membranes were blocked in PBS containing 5 % low fat 
milk powder and 0.2% Tween 20 for 20 min and then incubated in fresh 
blocking solution with HRP-conjugated  streptavidin at 1 #g/ml for 1 h at 
room temperature. Membranes were washed for 20 rain in TBST (10 mM 
Tris pH 8.0, 150 mM NaCI, 0.05%  Tween 20) and HRP-streptavidin  was 
visualized using an enhanced chemiluminescence (ECL) kit (Amersham 
Corp.) and exposure to x-ray film (Fuji XR) at room temperature. 
Determination of the Transfected CD44H Half  Life 
3  ×  106 MDCK cells were plated into 35-ram tissue culture dishes and in- 
cubated overnight in low calcium (5/~M CaC12)-DME plus 10% dialyzed 
FCS. The cells were then washed twice with high calcium (1.8 mM CaC12) 
DME without cysteine or methionine (DME-cys/met), and then incubated 
in 1 ml of (DME-cys/met) plus 5% dialysed  FCS, 0.3 mCi 35S-trans label 
(ICN Biomedicals, Inc., Costa Mesa, CA) and 5 % complete DME for 18 h. 
Cells were then washed and incubated in complete DME plus 10% FCS for 
a further 0 to 24 h. Cells were lysed in 0.4 ml NDET, CD44H was immuno- 
precipitated as described above, solubilized in reducing sample buffer and 
separated on a 10% SDS-polyacrylamide  gel. The gel was fixed, enhanced 
in 1 M  sodium salicylate  for 40 rain, dried and exposed  to x-ray film at 
-760C.  Labeled protein was quantified  by excising  sections of the poly- 
acrylamide gel, rehydrating  in 50-100/~1 H20, incubating in 0.45 rul NCS 
tissue solubilizer (Amersham Corp.) for 24 h at room temperature followed 
by 1 h at 45"C, neutralizing with the addition of 25 td glacial acetic acid 
and counting in 4.5 ml Aquascint H (National Diagnostics Inc., Manville, 
NJ) scintillation fluid. 
Detergent Extraction of Cells 
Cells were grown to confluence on 35-ram tissue culture dishes, extracted 
with varying concentrations of Triton X-100 and the distribution of protein 
between the detergent soluble and insoluble fractions was assayed by immu- 
noblotting as previously described (Neame and Isacke,  1992).  CD44 was 
detected using an ascites preparation of mAb El/2 at a dilution of 1:2,500 
or mAb IM7 hybridoma supernatant  at a dilution of 1:4, transferrin receptor 
and annexin II were detected using mAb H68.4  at 0.2 t~g/ml and anti- 
annexin II polyclonal antiserum at a dilution of 1:10,000, respectively  fol- 
lowed  by  125I-anti-mouse  or  anti-rat  Ig  (50,000  cpm/ml)  or  HRP- 
conjugated anti-mouse or anti-rabbit Ig (0.2 t~g/ml). 125I was detected by 
exposure of the blot to x-ray  film with an intensifying screen at  -76°C, 
HRP-antibodies were visualized using the ECL kit. 
Results 
Expression of Vdld-type CD44H and a Tailless (T-) 
Mutant in MDCK Cells 
A cDNA clone encoding the haematopoietic form of human 
CD44 (CIM4H) was isolated and a tailless (T-) mutant was 
Figure  L  Expression of CD44  in transfected MDCK  cell lines. 
Semi-confluent cultures of MDCK cells were lysed in nonreducing 
sample buffer and samples containing 20 tzg of protein were run in 
duplicate lanes on a 10% polyacrylamide gel and blotted onto nitro- 
cellulose, a  was probed with the human specific anti-CIM4 mAb, 
El/2, and an HRP-eonjugated anti-mouse Ig. b  was probed with a 
species cross-reactive anti-CD44 mAb, IM7, and an HRP-eonjugated 
anti-rat Ig. (lane 1) F1084  human fibroblasts; (lane 2) cloned  MDCK 
cell line expressing human WT CIM4H; (lane 3) clonal MDCK cell 
line expressing human T- CD44H; (lane 4) clonal MDCK cell line 
transfected with pSRu-neo vector alone. Blots were developed with 
the ECL reagent and exposed to x-ray film for 30 s. Molecular size 
markers are in kilodaltons. 
generated whereby a  cysteine codon located three amino 
acids after the putative transmembrane domain was changed 
to a TGA stop codon. For permanent expression, both the 
WT and T- CD44H were inserted into the eukaryotic expres- 
sion vector, pSRc~-neo, and transfected into MDCK epithe- 
lial cells. G418 resistant clonal cells lines were tested for ex- 
pression using the El/2 mAb which is specific for human 
CD44 and does not react with the endogenous canine CD44. 
Immunoblots of MDCK cells transfected with the human 
WT CD44H demonstrates the presence of a protein species 
with mol wt 80-90 kD similar to that recognized in human 
fibroblasts (Fig. 1). Cells transfected with the T-CD44H mu- 
tant produce a protein with reduced molecular weight con- 
sistent with the loss of a 7-kD cytoplasmic domain. Probing 
parallel immunoblots with a species cross-reactive antibody, 
mAb IM7, demonstrates that MDCK cells express two major 
forms of CD44. Approximately 30-50 % of the CD44 is the 
haematopoietic form and 50-70% resolves as higher molec- 
ular weight proteins consistent with the presence of the alter- 
natively spliced forms of CD44 previously observed in epi- 
thelial cells (Omary et al.,  1988; Stamenkovic et al.,  1991; 
Jackson et al.,  1992; Fig.  1). 
Localization of WT and T- CD44H 
in MDCK Monolayers 
Transfected MDCK cells were examined by immunofluores- 
cence to determine the cellular localization of the endoge- 
nous and human CD44 protein. Initially, the cells were cul- 
tured  to  confluence on glass  coverslips and  stained  with 
either rnAb IM7 or mAb El/2 (Fig. 2). It can be seen that 
Neame and Isacke Regulation of CD44 by Its Cytoplasmic Tail  1301 Figure 2. Localization of CD44 in polarized MDCK cells by fluorescence microscopy. Clonal MDCK cell lines transfected with pSRa-neo 
vector alone (a and b), WT CD44H (c and d) or T- CD44H (e and f) were cdtured to confluence on glass coverslips and then stained 
with mAb IM7 and an FITC-anti-rat Ig (a, c, and e) or mAb El/2 and an FITC-anti-mouse Ig (b, d, and f). Bar, 10/zm. 
the endogenous canine CD44, recognized by mAb IM7, is 
localized to  the  lateral  surface  and  focusing through  the 
monolayer showed little or no basal or apical staining.  An 
identical pattern of staining is observed with mAb El/2 in 
cells transfected with the human WT CD44H. From these 
data it appears that the presence of additional exons in the 
extracellular domain of  the epithelial form of CD44 does not 
alter its pattern of cellular expression. By contrast, removal 
of the cytoplasmic tail dramatically alters the localization of 
the  protein  in  MDCK  cells.  There  is  little  evidence  of 
basolateral staining, rather the T- protein appears to be local- 
ized to the apical plasma membrane. This was confirmed by 
repeating this experiment with non-permeabilized cells (data 
not shown). In addition, there is a distinct punctate cytoplas- 
mic distribution of the T- CD44H protein with the nuclei be- 
ing clearly defined. Finally, we consistently find that the ex- 
pression  of the T- CD44H  in these confluent monolayers 
exhibits cell to cell heterogeneity. 
To study these distributions  in  more detail,  transfected 
cells cultured on transwell filters were examined in the con- 
focal microscope. The confocal microscope allows optical 
sections to be cut either in the horizontal plane (XY section; 
see Fig. 3, a and b) or in the vertical plane (XZ section). The 
XZ sections show that both the endogenous and transfected 
WT protein (Fig. 3, c, e, g, and h) are tightly confined to 
the lateral membrane with no detectable CD44 on the apical 
or basal plasma membranes. To ensure that the lack of ob- 
servable basal WT CD44H staining was not due to interfer- 
ence from the nitrocellulose filter, vertical XZ confocal sec- 
tions were also examined on cells cultured to confluence on 
glass coverslips. Under these culture conditions, the MDCK 
cells do not achieve the height observed with cells cultured 
on filters. Again, only lateral staining of the WT CD44H is 
observed (Fig. 3 i) even though the mAb clearly penetrates 
the permeabilized cell monolayer to the level of the cover- 
slip.  The T- CD44H (Fig. 3, d,f, and j) is observed on the 
apical surface but it is not restricted to the plasma membrane 
as punctate intracellular staining is seen in the apical half of 
the cell with the nucleus clearly excluded. Again, these sec- 
tions show the cell to cell heterogeneity of the T- CIM4H ex- 
pression.  The distribution of WT CIM4H and T- CD44H 
described here was identical in all individual clonal transfec- 
tants examined. 
To quantify the expression of WT and T- CD44H to the 
different  plasma  membrane  domains  of  epithelial  cells, 
confluent monolayers of transfected cells were biotinylated 
on either the apical or basolateral surfaces as described in 
Materials and Methods. The cells were then lysed, the trans- 
fected CD44H was immunoprecipitated and the extent of bi- 
otinylation was assessed by probing nitrocellulose blots with 
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CD44  in  polarized  MDCK 
cells by confocal microscopy. 
Clonal  transfected  MDCK 
cell  lines  expressing  WT 
CD44H (a, c, e, g, and i) or 
T- CD44H (b, d, f, h, and j) 
were  cultured  to  confluence 
on  transwell  filters  (a-h)  or 
glass coverslips  (i and j) and 
stained  with  mAb  El/2  and 
FITC-anti-mouse  Ig  (a-f,  i 
and  j) or mAb IM7 and FITC- 
anti-rat  Ig (g and h).  a  and b 
show XY sections through the 
cells  in  the  same  plane  as 
shown  in  Fig.  2.  The  lower 
panels (c-j) show XZ sections 
taken in 0.1 t*m steps through 
the cells  at 90°C to the  XY 
sections;  the apical region of 
the cells is orientated topmost. 
Bar,  10 pro. 
HRP-conjugated streptavidin (Fig. 4). In agreement with the 
microscopic observations, <7 % of  the WT CD44H is acces- 
sible  to biotinylation  from the apical  side and conversely, 
<5 % of the T- CD44H is accessible to biotinylation from the 
basolateral  side. 
The Cytoplasmic Tail of CIM4H Is Important 
for Protein Stability 
Mistargeting  of proteins  in epithelial  cells  can lead to re- 
duced stability (Wollner et al.,  1992), To determine whether 
this is true for the T- CD44H, transfected MDCK cells were 
labeled to steady state with 3~S-tmns label and then chased 
Figure 4. Cell surface biotinylation  of CD44H in polarized MDCK 
cells.  Clonal transfected  MDCK cell lines expressing  WT CIM4H 
or T- CD44H were grown to confluence on duplicate  transwell  ill- 
ters and biotinylated  either from the apical (,4) or from the basolat- 
eral (B)  side.  CIM4H was immunoprecipitated with mAb El/2, 
resolved on a 10% polyacrylamide gel and blotted onto nitrocellu- 
lose.  Biotinylat~ protein was visualized  using HRP-streptavidin 
and the ECL reagent.  Blots were exposed to x-ray film for 1 h. Mo- 
lecular size markers are in kilodaltons. 
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transfected  MDCK cell lines expressing WT CD44H or T- CD44H 
were labeled  with 35S-trans label  to steady state  and then chased 
in unlabeled  medium for 0-24 h  as described in Materials  and 
Methods.  CD44  was  immunoprecipitated  with  mAb  El/2  and 
resolved on a  10%  polyacrylamide gel.  Enhanced gels were ex- 
posed to x-ray film for 5 d. Molecular size markers are in kilodal- 
tons. CD44 protein was excised  from the gel, solubilized  and the 
amount of label  incorporated measured by scintillation  counting. 
in unlabeled medium for 0-24 h  (Fig. 5).  Quantification of 
this data, and that from separate experiments,  indicates that 
the WT CD44H has a half life of 15-17 h.  The stability of 
the T- CD44H is two- to fourfold reduced compared to its 
WT CD44H counterpart. 
The Cytoplasmic Tail of CD44H Is Not Required 
for Interaction with the Cytoskeleton 
Several  laboratories  have  previously  demonstrated  that  a 
proportion of the CD44H population is resistant to 0.5-1% 
Triton X-100 detergent extraction.  These and other experi- 
ments have led to the suggestion that CD44 is associated with 
the  underlying  cytoskeleton.  To  determine  whether  the 
removal of the cytoplasmic tail or the presence of additional 
exons  in  the  higher  molecular  weight  epithelial  forms  of 
CD44 alters this association with the cytoskeleton, MDCK 
cell transfectants  were incubated in varying concentrations 
of Triton X-100 and the amount of CD44 in the detergent 
soluble and insoluble extracts was assayed by immunoblot- 
ting. All forms of endogenous canine CIM4 are completely 
extracted  from the  MDCK  cells  with  0.4%  Triton  X-100 
(Fig. 6 a). Under these experimental conditions, using three 
independently isolated clonal cell lines for each transfectant, 
we were unable to detect any reproducible differences be- 
tween the detergent extraction profile of the endogenous ca- 
nine CD44 (Fig.  6  a),  the transfected WT CD44H (Fig.  6 
b), the T- CIM4H (Fig. 6 c) and endogenous canine transfer- 
rin receptor (Fig. 6 d).  As a control for these experiments, 
the detergent  solubility of annexin II (previously known as 
p36,  calpactin I  and lipocortin II) was assayed in parallel. 
Annexin II is known to associate with the cortical cytoskele- 
ton  (Greenberg  and  Edelman,  1983;  Lehto et  al.,  1983; 
Figure 6.  Detergent  extraction  of CD44H  from  MDCK  cells. 
Confluent cultures of  MDCK cell clones transfected with pSRa-neo 
vector alone (a),  WT CD44H (b) or T- CD44H (c-e) were ex- 
traeted with varying concentrations of Triton X-100 as detailed  in 
Materials  and Methods.  The insoluble cell pellet (P) and the deter- 
gent soluble extract (S) were resolved on 10% polyacrylamide gels, 
blotted onto nitrocellulose  and probed with mAb IM7 and 125I-anti- 
rat  Ig (a),  mAb El/2  and  125I-anti-mouse Ig (b  and  c),  H68.4 
anti-transferrin  receptor  mAb and  HRP-anti-mouse Ig (d),  and 
anti-annexin  1I antiserum and  HRP-anti-rabbit  Ig (e).  Blots a-c 
were exposed to x-ray film for 1-3 d; blots d and e were visualized 
using an ECL kit and exposed to x-ray film for 60 and  10 min, 
respectively. Molecular size markers are in kilodaltons, fshows the 
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Parallel  dishes  of F1084  human  fibroblasts  were extracted  with 
varying concentrations of Triton X-100 and the amount of CD44H 
(a), transferrin receptor (b) and annexin II (c) in the insoluble cell 
pellet (P) and detergent soluble extract (S) was assayed, d  shows 
the average protein content of the insoluble cell pellet (P: hatched 
bars) and detergent soluble extract (S: shaded bars) as a percentage 
of total protein,  i.e.,  S  +  P.  Molecular size markers are in kilo- 
daltons. 
Nigg et al.,  19-83;  Gerke and Weber,  1984) and in MDCK 
cells, >90% of the armexin H is insoluble in the presence of 
0.4%  Triton  X-100  (Fig.  6  e).  As  these  CD44  extraction 
results were in disagreement with data from other laborato- 
ries it was important to repeat these experiments in another 
cell type. Initially, F1084 human fibroblasts, which have en- 
dogenous expression of CD44H,  were examined.  Approxi- 
mately 50%  of the F1084 CD44H  remains in the detergent 
insoluble  cell  pellet in the presence  of 0.4%  Triton  X-100 
while 75-85 % of the cell protein is extracted (Fig.  7, a  and 
d). In parallel immunoblots, in the presence of 0.4%  Triton 
X-100 >90%  of the transferrin receptor is detergent soluble 
(Fig.  7  b)  whereas  >90%  of the annexin  II remains  in the 
detergent insoluble cell pellet (Fig. 7 c). The solubility of the 
average protein content of the insoluble cell pellet (P: hatched bars) 
and detergent soluble extract (S: shaded bars) as a percentage of 
total protein,  i.e.,  S  +  P.  Each value varied <7%  between the 
different cell lines. 
Figure 8. Detergent extraction of CD44H from transfected murine 
fibroblasts. Parallel dishes of clonal Swiss 3T3  cell lines (a) and 
NIH 3'I"3 cell lines (b) expressing WT and T- CD44H were either 
lysed whole or extracted with 0.4%  Triton X-100. The amount of 
CD44H in the total cell lysate (T), insoluble cell pellet (P),  and 
detergent soluble extract (S) was assayed. Parallel dishes of Swiss 
3T3 cells in which 60-80%  of the cells were expressing WT (c), 
T- (d) or PT16 tailless (e) CD44H were extracted with varying con- 
centrations of Triton X-100 and the amount of CD44H in the insol- 
uble cell pellet (P) and detergent soluble extract (S) was assayed. 
Molecular size markers are in kilodaltons. 
transferrin  receptor suggests that under these experimental 
conditions  the fibroblast plasma membrane is fully soluble 
and that the retention of CD44 does not result from lipid en- 
trapment as has been recently reported for certain GPI an- 
chored  proteins  (Brown  and  Rose,  1992).  Swiss  3T3  and 
NIH  3T3  fibroblasts  transfected  with  the  human  WT  or 
T- forms of CD44H were then examined under the same con- 
Neame and Isacke Regulation of CD44 by Its Cytoplasmic Tail  1305 Figure 9. Localization of CD44H and atmexin II in detergent extracted  fibroblasts by fluorescence microscopy. F1084 human fibroblasts 
(a and b) and Swiss 3T3 cells expressing WT (c and d) or T- (e and  f) CD44H were cultured at low density on glass coverslips, extracted 
with 0.4%  Triton X-100, fixed with paraformaldehyde  and stained with El/2 anti-CD44 mAb and anti-annexin  II antiserum followed by 
noncross-reactive  FITC-anti-mouse  and rhodamine-anti-rabbit  Ig. The CD44 associated FI'IC stain is shown in a, c, and e while the anti- 
atmexin II associated  rhodamine stain is shown in b, d, and f. Bar,  10/~m. 
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gent solubility of the WT and T- CIM4H (Fig. 8) with >50% 
of both the WT and T- CD44H remaining in the detergent 
insoluble cell pellet in the presence of 0.4% Triton X-100. 
The T- CD44H mutant contains three carboxy terminal argi- 
nine residues after the predicted transmembrane domain. To 
determine whether these basic residues were responsible for 
the detergent insolubility of the T- CD44H, a second tailless 
mutant, PT16 CD44H, was generated whereby the three ar- 
ginine residues  were  replaced  by arg-trp-thr-COOH.  No 
difference was detected in the detergent solubility of the 
PT16 CD44H and T- CD44H (Fig. 8, d and e). 
To further investigate the association of endogenous and 
transfected CD44 with the cytoskeleton, fibroblast cells ex- 
tracted with detergent were examined by immunofluorescence 
(Fig. 9). The staining pattern of both WT and T- CD44H in 
detergent extracted fibroblasts was in a  three dimensional 
punctate reticulurn which defined the edges of the cell. A 
significant degree of colocalization was observed between 
CD44 and cytoskeletally-associated annexin II. 
Discussion 
Removal of the CD44 Cytoplasmic Tail Results in a 
Redistribution of the Protein in MDCK Cells 
In this paper we have examined the influence of the cytoplas- 
mic domain on the behavior of CD44H.  Biochemical and 
morphological data (Figs. 2, 3, and 4) demonstrate that both 
CIM4H and the higher molecular weight epithelial forms of 
CIM4 are  localized to the basolateral  surface of MDCK 
cells. However,  a mutant of CIM4H which lacks the cyto- 
plasmic tail shows a different distribution in that it is found 
on the apical plasma membrane and a proportion within the 
cell. 
The basolateral localization of the WT CD44H suggests 
that it is either directly targeted to this site or it is initially 
delivered elsewhere and rapidly redistributed basolaterally. 
By contrast, the T- form must be either excluded from the 
basolateral membranes or rapidly redistributed subsequent 
to basolateral delivery. This implies that the CIM4 cytoplas- 
mic tail contains sequences required for basolateral target- 
ing  and/or  stabilization  in  the  basolateral  membrane. 
CIM4H is normally a  resident plasma membrane protein 
(Bretscher et al., 1980; Jacobson et al., 1984) and therefore, 
it cannot be involved in endocytotic events usually associated 
with  the  rapid  redistribution  of transmembrane proteins 
from one plasma membrane domain to another. This sug- 
gests that the steady state distr~ution of CIM4 is likely to 
be determined by its primary targeting. Recent experiments 
have demonstrated the existence of specific basolateral tar- 
geting sequences (reviewed Hopkins,  1991; Mostov et al., 
1992) which in turn suggest that the T- CD44H cannot reach 
its final destination via the basolateral domain. Mutational 
analysis of basolateraUy targeted proteins has suggested that 
they fall into two classes; (a) those such as the IgG Fc recep- 
tor and lysosomal membrane glycoprotein, lgp 120, where 
the basolateral targeting information is intimately linked to 
the coated pit internalization signal (Hunziker et al., 1991), 
and (b) proteins such as the low density lipoprotein (LDL) 
receptor and the polymeric IgA/IgM (pig) receptor where 
the basolateral sorting signal is spatially distinct from the in- 
ternalization signal (Casanova et al.  1991; Hunziker at al. 
1991; Yokode et al., 1992).  Sequence comparison of the re- 
gion encompassing the basolateral sorting signal in the LDL 
and pig receptors shows a 10 amino acid consensus (Yokode 
et al., 1992). An examination of the CD44 cytoplasmic tail 
shows no evidence for a clathrin coated pit internalization 
signal. There is a partial sequence homology at the extreme 
carboxyl terminus of CD44 with the potential basolateral 
sorting consensus region and a somewhat stronger homology 
when compared directly to the rabbit poly Ig receptor. Cen- 
tral to this partial homology is the amino acid stretch asn-val- 
asp (amino acids 354-356 in human CD44H). 
CD44 is Restricted to the Lateral Surface 
of  Polarized MDCK Cells 
In MDCK cells, the majority of the basolateral CD44, both 
CD44H  and  the  alternatively spliced  epithelial  forms of 
CD44, is found on the lateral membranes with little being 
apparent on the basal membranes (Figs. 2 and 3). This sug- 
gests that CD44 might play a role in cell to cell interaction 
in epithelial cells. Other laboratories have reported that a 
significant  proportion  of  CD44  is  associated  with  the 
cytoskeleton (Jacobson et al.,  1984;  Tarone et al.,  1984; 
Lacy and Underhill, 1987; Carter and Wayner,  1988; Kalo- 
miris and Bourguignon, 1988;  Camp et al.,  1991; Lokesh- 
war and Bourguignon,  1991). Initially we investigated the 
possibility that the lateral distribution of CD44 was due to 
an interaction with the cytoskeleton  by extracting the MDCK 
cells with detergent. These experiments gave an unexpected 
result. All the endogenous canine CIM4 forms and the trans- 
fected WT and T- CD44H were completely extracted from 
the MDCK cells in 0.4% Triton X-100 (Fig. 6). This result 
is not due to an inability of MDCK proteins to form Triton 
X-100 insoluble interactions as Salas et al. (1988) and Nel- 
son  et  al.  (1990)  have  demonstrated  that  a  number  of 
cytoskeletally  associated  plasma  membrane  proteins  in 
MDCK cells are resistant to detergent extraction. Further, 
in our MDCK cell experiments, we have demonstrated that 
a cytoskeletally  associated protein, annexin II, is essentially 
detergent insoluble. Although the CD44 proteins are fully 
extracted in 0.4% Triton X-100, they are mostly insoluble in 
0.05 % Triton X-100. At this lower detergent concentration 
almost 60 % of the total cellular protein is released into the 
soluble fraction. One interpretation of these results is that 
CD44 does interact with the MDCK cytoskeleton albeit in 
a manner that it sensitive to higher detergent concentrations. 
However, a transmembrane protein which does not associate 
with the cytoskeleton, the transferrin receptor, showed a de- 
tergent extraction profile similar to the CD44 proteins (Fig. 
6). These data suggests that in MDCK cells, CD44 has no 
detergent insoluble association with the cytoskeleton and 
therefore such an association cannot regulate the tight lateral 
restriction of CD44. 
An alternative possibility for the control of CD44 localiza- 
tion to the lateral membrane is an interaction between the ex- 
tracellular domain and proteins expressed on neighboring 
cells or an element of the extracellular matrix found only in 
these lateral regions. CD44H is a receptor for hyaluronate 
(Arnffo et al.,  1990;  Lesley et al.,  1990)  but binding to 
hyaluronate is unlikely to be the main mechanism for deter- 
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the higher molecular weight epithelial forms of CD44 have 
been shown to have a diminished ability to bind hyaluronate 
(Stamenkovic et al., 1991) and yet they are tightly localized 
to the lateral surface, and (b) when intestinal epithelial sec- 
tions are examined, CD44 can be clearly observed on the 
lateral membranes whereas hyaluronate is excluded from 
this area but is abundant in the basement membranes (Alho 
and Underhill, 1989). CD44 has been reported to bind to the 
extracellular matrix molecules, type I and type IV collagen 
(Wayner  and  Carter,  1987; Faassen  et  al.,  1992)  and 
fibronectin (Jalkanen and Jalkanen, 1992) and to a hetero- 
typic ligand on the plasma membrane of mouse fibroblasts 
cells (St.  John et al.,  1990).  It remains to be determined 
whether any of these types of interaction might have some 
role in localizing CD44 to the lateral membrane of MDCK 
cells as opposed to the general basolateral domain. 
The Association of CD44 with the 
Cytoskeleton Does Not Require the Cytoplasmic Tail 
and Is Dependent upon Cell ])pe 
The detergent extraction experiments were extended to look 
at CD44 in fibroblasts. In agreement with data from other 
laboratories,  a  significant proportion  of the  endogenous 
CD44H in human fibroblasts is resistant to Triton X-100 ex- 
traction (Fig. 7) suggesting that in these cells, CD44 can as- 
sociate with the cytoskeleton.  To  further investigate this 
phenomena we examined the distribution of CD44 in deter- 
gent extracted human fibroblasts by immunofluorescence. 
Carter and Wayner (1988) have previously described the dis- 
tribution  of CD44  in  detergent  extracted  WI-38  human 
fibroblasts as having a "distinct fibrillar pattern defining the 
cell periphery and many closed loops over the cells body" 
and an essentially similar distribution was observed in our 
F1084 human fibroblast experiments (Fig. 9). This fibrillar 
pattern does not codislribute with fibronectin, collagen or 
actin containing stress fibres (Carter and Wayner, 1988) al- 
though disruption of the actin cytoskeleton does increase the 
amount of detergent soluble CD44  (Lacy and Underhill, 
1987). Using CD44 reconstituted into liposomes, Kalomiris 
and Bourguignon (1988) have demonstrated an in vitro as- 
sociation of CD44 with ankyrin while Carter and Wayner 
(1988) have demonstrated a codistribution of CD44 with the 
intermediate filament protein, vimentin. There is evidence 
that ankyrin and vimentin can interact directly with each 
other (Georgatos and Marchesi,  1985) and also with spec- 
trin, a major component of the cortical cytoskeleton (Man- 
geat and Burridge, 1984).  As annexin II is known to codis- 
tribute with spectrin (Greenberg and Edelman, 1983; Lehto 
et al.,  1983;  Gerke and Weber,  1984),  we performed dou- 
ble-labeled immunofluoresence experiments with an anti- 
annexin II antisera. A considerable degree of  overlap was ob- 
served between the staining patterns for CD44 and annexin 
II  (Fig.  9)  implying that the detergent insoluble pool of 
CD44 is associated with the submembraneous skeleton of 
fibroblasts. 
Deletion of the CD44 cytoplasmic tail does not alter its 
detergent extraction profile (Fig. 8) nor the distribution of 
the protein in Triton X-100 treated cells (Fig. 9). In a recent 
report, Carpen et al. (1992) have demonstrated that o~-actinin 
can bind to the cytoplasmic domain of ICAM-1 and that this 
binding can be mimicked using a  5 amino acid positively 
charged peptide identical to a short ICAM-1 sequence close 
to the transmembrane spanning domain. To exclude the pos- 
sibility that the interaction of T- CD44H with the cytoskele- 
ton was mediated by a similar mechanism, a second tailless 
mutant, PT16  CD44H,  was examined and shown to have 
properties indistinguishable from the T- CD44H. (Fig. 8, d 
and e). This leads to the conclusion that the cytoplasmic do- 
main is not responsible for the detergent insoluble interac- 
tion and that this function must therefore be mediated by 
some other portion of the CD44 molecule. This interaction 
could be either direct, as has been suggested for the CD8 
molecule  (Andr6  et  aL,  1991), or  indirect,  for example 
through co-association with the extracellular matrix. This 
latter possibility is not supported by experiments from other 
laboratories where extracellular matrix components includ- 
ing hyaluronate were removed by enzyme digestion with lit- 
tle effect upon the detergent extraction profile of CD44 (Ta- 
rone et al.,  1984;  Lacy and Underhill,  1987). 
A comparison between the detergent extraction of CD44 
in the epithelial and fibroblast cell lines (Figs. 6, 7, and 8) 
clearly demonstrates that in the presence of 0.4%  Triton 
X-100, a significant proportion of fibroblast CD44 remains 
in the detergent insoluble cell pellet whereas in epithelial 
cells essentially all the CD44 is detergent soluble.  These 
results imply that whatever the mechanism is by which CD44 
is associated with the cytoskeleton  in fibroblasts, this mecha- 
nism does not operate in MDCK cells. If a second protein 
interfaces between CD44  and the  fibroblast cytoskeleton 
then the absence of such a protein, or its modification, could 
explain the results obtained with the MDCK cells. In this 
context it is interesting that Camp et al. (1991) have shown 
that in resident peritoneal macrophages there is a population 
of detergent insoluble CD44 while in elicited macrophages 
all of the CD44 is detergent soluble. 
A Population of T- CD44H is Localized Intracellularly 
In immunofluorescence experiments we observe a propor- 
tion ofT- CD44H localized with a distinct punctate distribu- 
tion within MDCK cells. This distribution suggests that in- 
tracellular T-  CD44H  probably resides  in membranes of 
small vesicles.  Immunoblotting of transfected cells shows 
that there is a smaller molecular weight form of T- CD44H 
(see Figs. 6 c  and 7 f; mol wt 55-65 kD) which is found in 
all the T- CD44H cell lines, however,  the presence of this 
form is variable and may be dependent on culture condition. 
What is known is that this smaller form is not expressed on 
the cell surface as it is never detected when cells are surface 
labeled with biotin or 125I, it is consistently more suscepti- 
ble to detergent extraction than the higher molecular weight 
form (see Fig. 8 b) and it retains at least a portion of the ex- 
tracellular domain containing the mAb epitope. It remains 
to be  determined whether this smaller T-  CIM4H form, 
which contributes to the intracellularly localized T- CD44H, 
results from protein which has not reached the cell surface 
or protein which has been expressed on the cell surface, in- 
ternalized and then partially degraded. 
To enable us to examine the stability of the T- CD44H pro- 
tein, MDCK cells were plated into culture dishes in low cal- 
cium medium for 24 h prior to the 35S-labeling in complete 
medium. The low calcium medium prevents the formation 
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of proteins to specific membrane domains  (Nelson  et al., 
1990), and under these culture conditions we only detect the 
higher molecular weight form of T- CD44H. In these experi- 
ments, it was demonstrated that removal of the cytoplasmic 
tail  reduces  the  stability  of the  CD44H  protein  (Fig.  5). 
Electron microscopy studies have shown that CD44H is ex- 
cluded from the coated pits on the cell surface (Bretscher et 
al., 1980; Hopkins 1986). One explanation for the reduction 
in the T- CD44H stability is that removal of the cytoplasmic 
tail allows entry into the coated pit and hence, the protein 
is more rapidly internalized and degraded than the WT coun- 
terpart.  A  similar conclusion has been drawn for the CD4 
protein which in lymphocytes is excluded from the coated 
pits due to its association with p50  ok. Deletion of the cyto- 
plasmic tail abolishes this interaction and results  in an in- 
creased rate of CD4 endocytosis (Pelchen-Matthews et al., 
1991).  An increased rate of internalization might account, at 
least in part, for the intracellular localization of the T- CD44H 
and the presence of the 55-65 kD form. Morphological ex- 
amination  of  MDCK  cells  has  shown  that  in  confluent 
monolayers there is consistent heterogeneity of T- CD44H 
expression (Figs. 2 and3). The reason for this heterogeneity 
of expression is not known but it does not result from hetero- 
geneity within the clonal cell line illustrated  here, as all the 
clonal T- CD44H transfected  MDCK cell lines tested gave 
the same result, and when plated sparsely and examined by 
immunofluorescence each cell expresses T- CD44H to a uni- 
form level. 
Goldstein et al. (1989) have isolated a cDNA clone encod- 
ing a tailless CD44H molecule with almost identical struc- 
ture to the T- CD44H described here. In the cell lines exam- 
ined, a truncated  CD44 was only detected at very low levels 
(Goldstein and Butcher,  1990) and it is therefore unlikely to 
play an important physiological role unless its expression is 
elevated in cells which are as yet untested. A tailless mutant 
was used by Lesley et al. (1992) to examine the hyaluronate 
binding capacity of CD44H molecules transfected  into the 
CD44-ve  AKR1  T lymphoma cell line.  This mutant  had a 
much reduced capacity to bind hyaluronate  in solution but 
partially  retained  the  ability  to  adhere  to  immobilized 
hyaluronate.  Anti-CD44  mAb could enhance the hyaluro- 
nate binding capacity of the truncated CD44 protein suggest- 
ing  that  hyaluronate  binding  requires  a  conformational 
change in CD44 or a redistribution of the protein on the cell 
surface. These results are compatible with the data presented 
here  showing  that  the  CD44  cytoplasmic  tail  does  not 
directly mediate interaction with the cytoskeleton but is im- 
portant  for membrane localization. 
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